CB Insights – As medical device companies gain traction, large corporates such as Medtronic, Boston Scientific, and Teleflex are competing in the race to acquire private medical device startups targeting neurosurgery, orthopedics, and cardiology, among other areas.
FierceBiotech – BD has struck a $24 billion deal to buy C.R. Bard. The takeover will strengthen BD’s position in the markets for catheters, pumps and other items while also giving it a bigger presence in fast-growing fields including oncology and biosurgery.
In an exciting year for healthcare, orthopedic device companies underwent mergers and acquisitions, strove to find the most innovative solutions and made calculated decisions in the hopes of achieving long-term success as the market becomes increasingly competitive.
The new Trump administration and Republican Congress – and all the accompanying change and uncertainty – is the major story for the medical device industry.
This was yet another year filled with mergers and acquisitions in the medical device industry, with several mega-deals valued well over $1 billion. Many of
In June 2014, Medtronic and Covidien shook the medical technology industry with the announcement of a merger of unprecedented scale. OCTANe’s Medical Investor Forum, held
Despite global challenges and escalating consolidation, the medical device and technology market will eclipse $500 billion in sales by 2021, according to a new analysis.
There is a trope used by motivational speakers that the Chinese word for “crisis” is a combination of the symbols for “danger” and “opportunity.” It
While some analysts see a buying opportunity after Zimmer Biomet’s (ZBH) latest quarterly results, it is the company’s efforts to return to growth that could
While some analysts see a buying opportunity after Zimmer Biomet’s (ZBH) latest quarterly results, it is the company’s efforts to return to growth that
The days of mega deals in medtech will continue, according to one M&A expert, but the overall number of acquisitions of all sizes may dip—for
Alphatec (NSDQ:ATEC) said today it entered into an agreement with Globus Medical (NYSE:GMED) to sell its international operations and distribution channels for $80 million. Alphatec said the deal
Zimmer Biomet ($ZBH) flexed some of its cash-on-hand muscle and has entered into the growing surgical robotics arena with the purchase of France’s Medtech for
Innovative new product launches and acquisition of new technologies appear to be commonalities among major medtech companies enjoying especially robust stock price growth this year.
By now we all know how Medtronic knocked Johnson & Johnson JNJ from its indisputable position as the top firm in the medical devices space,
Wright Medical (NSDQ:WMGI) said today that it agreed to deal its large joints business to Corin Orthopaedics Holdings for about $33 million in cash. The €29.7
Zimmer Biomet (NYSE:ZBH) said today it is buying spinal medical device company LDR Holding for approximately $1 billion. Boards from both companies approved the acquisition agreement,
M&A in recent years has dramatically transformed the medtech industry, and executives have continued to sign deals, with several transactions worth hundreds of millions and
Abbott (NYSE:ABT) said today that it offered to pay a 37% premium for St. Jude Medical (NYSE:STJ) in a $25 billion deal aimed at expanding
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today that it has entered into a definitive agreement to